Twenty months after the Supreme Court ruled to return abortion policy to the states‚ the issue will be before the justices again on Tuesday‚ when they weigh a case that threatens to curtail access to a commonly used drug taken in a medication abortion. The dispute involves a series of actions that the Food and Drug Administration took beginning in 2016 that made the pill‚ mifepristone‚ easier to obtain. A group of medical associations that oppose abortion rights have argued the agency acted...